MDS Virtual Congress 2021 Archives - Page 36 of 132

Determination of the motor status after the implementation Levodopa-carbidopa intestinal gel in patients with advanced Parkinson’s disease using a Machine learning Algorithm

E. Efthymiopoulou, A. Antonoglou, B. Loupo, A. Bougea (Athens, Greece)
Determining the content of a clinician-rated tool for freezing of gait severity

A. Scully, B. de Oliveira, K. Hill, D. Tan, YH. Pua, R. Clark, E. Burton (Bentley, Australia)
Developing 31-phosphorus magnetic resonance spectroscopy (31P-MRS) as an imaging biomarker to identify mitochondrial dysfunction in Parkinson’s disease

T. Payne, M. Sassani, S. Roscoe, S. Bradley, A. Anton, E. Reed, I. Wilkinson, H. Mortiboys, T. Jenkins, O. Bandmann (Sheffield, United Kingdom)
Development of a remote physical exercise program during COVID-19 pandemic for individuals with Parkinson’s disease

C. Torriani-Pasin, T. Freitas, V. Domingues, B. Araújo, G. Palma, M. Makhoul, R. Andreotti, L. Mochizuki (Sao Paulo, Brazil)
Development of quantitative tools for in-home clinical assessment of people with Parkinson’s disease

T. Virmani, L. Pillai, A. Glover, A. Kemp, J. Utecht, H. Spencer, T. Nolan, M. Rutherford, P. Farmer, S. Syed, H. Eswaran, M. Lotia, J. Bona, L. Larson-Prior, F. Prior (Little Rock, USA)
Development of the CONSORTIUM FOR GLOBAL DIVERSITY IN PARKINSON’S DISEASE (CDG-PD) Patient Database

J. Bajwa, M. Salari, S. Khan, H. Amer, A. Al-Qassabi, A. Habib, J. Habib, M. Abu Al-Melh, M. Abu Snineh, Q. Un Nisa, S. Zaidi, A. Dahshan, W. Regragui, J. Ahmed, H. Shehata, I. Hashmat, N. Ullah Bullo, S. Om Mittal, T. Mohammad, W. Kamel, T. Houyam, S. Eljaffery, R. Rajan, M. Farghal, F. Abdulla, Z. Al-Daajani, P. Schmidt, H. Khalil (Riyadh, Saudi Arabia)
Development of the Huntington’s Disease Integrated Staging System (HD-ISS)

S. Tabrizi, S. Schobel, E. Gantman, A. Mansbach, B. Borowsky, P. Konstantinova, T. Mestre, A. Mullin, J. Panagoulias, K. Romero, C. Ross, S. Sivakumaran, E. Turner, M. Zauderer, J. Long, C. Sampaio (London, United Kingdom)
Development of the Parkinson’s Disease Medication Adherence Scale (PD-MAS)

M. Tosin, C. Goetz, G. Stebbins, B. Oliveira (Niteroi, Brazil)
Diabetes Mellitus in Huntington’s disease. The Argentinean perspective

N. Gonzalez Rojas, M. Cesarini, J. Etcheverry, E. Gatto (Buenos Aires, Argentina)
Diagnosis and management of Myoclonus Dystonia Syndrome: a Survey of the European Reference Network for Rare Neurological Diseases.

M. Vanegas, E. Timmers, F. Hamami, S. Boesch, W. Vandenberghe, O. Burgazlieva, M. Møller, L. Hjermind, M. Vidailhet, A. Meneret, T. Bäumer, S. Siegert, T. Gasser, L. Schoels, J. Molnar, A. Capuano, F. Nicita, G. Zorzi, A. Albanese, A. Federico, E. Lohmann, J. Guk, M. Willemsen, N. Wolf, M. Dec-Cwiek, D. Neubauer, D. Flisar, V. Gonzalez, A. Darling, M. Marti, H. Houlden, C. Reinhard, A. Weissbach, M. Tijssen, B. Perez-Dueñas (Barcelona, Spain)